JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265724

Human PTPN13 (FAP-1) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

PTPN13 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 14. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human PTPN13 (FAP-1) knockout HeLa cell line (AB265724)
  • Sanger seq

Unknown

Sanger Sequencing - Human PTPN13 (FAP-1) knockout HeLa cell line (AB265724)

Homozygous : 4 bp deletion in exon 14.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 14

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265724-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265724-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265724 Human PTPN13 (FAP-1) knockout HeLa cell line", "number":"AB265724-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265724-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265724-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265724 Human PTPN13 (FAP-1) knockout HeLa cell line", "number":"AB265724-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265724-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265724 Human PTPN13 (FAP-1) knockout HeLa cell line", "number":"AB265724-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265724-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265724 Human PTPN13 (FAP-1) knockout HeLa cell line", "number":"AB265724-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
PTPN13
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PTPN13 also known as FAP-1 or Fas-associated phosphatase-1 is a non-receptor type protein tyrosine phosphatase with a reported molecular weight of approximately 270 kDa. This enzyme contains several PDZ domains contributing to its interactions with other proteins. PTPN13 is expressed in various tissues including the brain liver and heart indicating its wide-ranging roles in cellular functions.
Biological function summary

PTPN13 plays a critical role in the regulation of apoptosis and cell-cell adhesion. It interacts with components of the cytoskeleton and other signaling proteins functioning as part of protein complexes involved in maintaining cellular structure and signaling. By dephosphorylating specific phosphotyrosine residues PTPN13 controls signaling pathways that determine cell survival and communication.

Pathways

PTPN13 is involved in pathways such as the Fas-mediated apoptosis signaling and insulin signaling pathways. It interacts with proteins like the Fas receptor and IRS1 within these pathways modulating signals that control apoptosis and metabolic responses. PTPN13's activity can affect downstream signaling events influencing cellular outcomes like survival or death in response to external stimuli.

Researchers have linked PTPN13 with cancer and insulin resistance. The protein's interaction with Fas-associated proteins suggests a role in tumorigenesis particularly related to apoptosis evasion. In the context of metabolic disorders PTPN13's function in the insulin signaling pathway connects it to insulin resistance where its regulation of IRS1 affects insulin response. These associations highlight the potential of targeting PTPN13 in therapeutic strategies for these diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com